CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival. (Q38955569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Rebeca Dieguez-Gonzalez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Silvana Novelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ana Mozos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Alberto Gallardo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Miguel Angel Pavón

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Miguel Angel Pavón

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Miguel Alcoceba

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Oscar J Blanco

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Marcos González Díaz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ramón Mangues

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Isolda Casanova

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

María Virtudes Céspedes

9

object named as

María Virtudes Céspedes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

María José Moreno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Albert Grañena

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jorge Sierra

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

11 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

445-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

16 February 2020

cites work

1 reference

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

21 January 2018

1 reference

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).

21 January 2018

1 reference

Chemokines and chemokine receptors in leukocyte trafficking

21 January 2018

1 reference

Chemokine control of lymphocyte trafficking: a general overview.

21 January 2018

1 reference

Chemokine requirements for B cell entry to lymph nodes and Peyer's patches.

21 January 2018

1 reference

Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination

21 January 2018

1 reference

Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

21 January 2018

1 reference

The significance of cancer cell expression of the chemokine receptor CXCR4.

21 January 2018

1 reference

Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma.

21 January 2018

1 reference

A novel inhibitor of focal adhesion signaling induces caspase-independent cell death in diffuse large B-cell lymphoma.

21 January 2018

1 reference

A novel orally available inhibitor of focal adhesion signaling increases survival in a xenograft model of diffuse large B-cell lymphoma with central nervous system involvement

21 January 2018

1 reference

Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma

21 January 2018

1 reference

The role of chemokine receptor CXCR4 in lung cancer

21 January 2018

1 reference

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

21 January 2018

1 reference

Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.

21 January 2018

1 reference

Chemokines in the brain: neuroimmunology and beyond

21 January 2018

1 reference

Current status of chemokines in the adult CNS.

21 January 2018

1 reference

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Lymphoma dissemination: the other face of lymphocyte homing

21 January 2018

1 reference

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia

21 January 2018

1 reference

Halting metastasis through CXCR4 inhibition

21 January 2018

1 reference

CXCR4 and axillary lymph nodes: review of a potential biomarker for breast cancer metastasis.

21 January 2018

1 reference

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

21 January 2018

1 reference

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

21 January 2018

1 reference

Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome

21 January 2018

1 reference

CXCR4 is a prognostic marker in acute myelogenous leukemia.

21 January 2018

1 reference

Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.

21 January 2018

1 reference

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.

21 January 2018

1 reference

Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140.

21 January 2018

1 reference

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231113%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference